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Deborah JL Wong1†, Lidia Robert1,8†, Mohammad S Atefi1, Amanda Lassen1, Geetha Avarappatt1,7, Michael Cerniglia1,
Earl Avramis1, Jennifer Tsoi2, David Foulad1, Thomas G Graeber2, Begonya Comin-Anduix3,4, Ahmed Samatar5,
Roger S Lo2,4,6 and Antoni Ribas1,2,3,4*Correction
After publication of this work [1], we noted that we re-
peatedly had a typo mistake across the manuscript. The
compound we used to test our cell lines was SCH772984
and not SCH722984. The typo was found misspelled in
54 occasions, including the title.
We also wanted to add an affiliation detail to the author’s
list, as noted above.
We regret the mistake and upload this note to clarify it.
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